Cargando…
Periostin in Osteoporosis and Cardiovascular Disease
CONTEXT: Osteoporosis (OP) and cardiovascular disease (CVD), prevalent disorders worldwide, often coexist and share common risk factors. The identification of common biomarkers could significantly improve patients’ preventive care. OBJECTIVES: The objectives are 1, to review periostin (Postn) involv...
Autores principales: | Pickering, Marie-Eva, Oris, Charlotte, Chapurlat, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285762/ https://www.ncbi.nlm.nih.gov/pubmed/37362382 http://dx.doi.org/10.1210/jendso/bvad081 |
Ejemplares similares
-
Cross-Talks between the Cardiovascular Disease-Sarcopenia-Osteoporosis Triad and Magnesium in Humans
por: Pickering, Marie-Eva
Publicado: (2021) -
Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
por: Chapurlat, Roland D
Publicado: (2009) -
Osteoanabolic Agents for Osteoporosis
por: Haas, Andrea V, et al.
Publicado: (2018) -
New Horizons: Artificial Intelligence Tools for Managing Osteoporosis
por: Dimai, Hans Peter
Publicado: (2022) -
Osteoporosis: the current status of mesenchymal stem cell-based therapy
por: Phetfong, Jitrada, et al.
Publicado: (2016)